Key result
Inoue balloon mitral commissurotomy expands mean mitral valve area by ~0.88 cm2 with high procedural success.
Why the study?
Immediate outcomes of percutaneous transvenous Inoue balloon mitral commissurotomy for severe rheumatic mitral stenosis in a regional Iraqi center were not previously reported.
Does Inoue balloon mitral commissurotomy using a percutaneous transvenous approach improve hemodynamic parameters and procedural success in patients with severe rheumatic mitral stenosis?
Observational (n=86)
No
Does Inoue balloon mitral commissurotomy using a percutaneous transvenous approach improve hemodynamic parameters and procedural success in patients with severe rheumatic mitral stenosis?
Inoue balloon mitral commissurotomy via a percutaneous transvenous approach is a safe and effective treatment for severe rheumatic mitral stenosis in a regional Iraqi cardiac center, achieving immediate hemodynamic and symptomatic improvements comparable to international outcomes.
Answers are grounded in this paper and cite their sources.
Supports real-world use in experienced centers; extends global observational data on Inoue balloon commissurotomy but leaves randomized confirmation needed.
Objective: Immediate outcomes of percutaneous transvenous approaches to inoue balloon mitral commissurotomy. Study Design: A single-center observational studyPlace and Duration of Study: This study was conducted at the Shaheed Almihrab Cardiac Center in Babylon‚ Iraq from 1st January 2021 to 31st December 2025. Methods: 86 patients with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm2 and Wilkins score ≤8) who underwent inoue balloon mitral commissurotomy were included. Pre- and post-procedural transthoracicechocardiography was performed on all patients. Mean mitral pressure gradient ‚ mean mitral valve area‚ pulmonary artery systolic pressure post-transcatheter pulmonary valve replacement‚ and mitral regurgitation (MR) severity were primary clinical end points. Procedural success was defined as mitral valve area >1.5 cm2 without severe mitral regurgitation (MR ≥3+). Results: The mean age was 38.4 ± 11.2 years. The majority of the patients were females (74.4%). Procedural success was 94.2%. Baseline mitral valve area was 0.91±0.18 cm2 ‚ increasing to 1.79±0.24 cm2‚ P<0.001. Mitralmean gradient decreased from 14.2±4.6 mmHg to 5.1±2.3 mmHg‚ P<0.001‚ and pulmonary artery systolic pressure decreased from 48.6±14.2 mmHg to 31.4±10.8 mmHg‚ P <0.001. Severe mitral regurgitation occurred in 3.5%‚cardiac tamponade in 1.2%‚ but no deaths were procedure-related. Conclusion: Inoue balloon mitral commissurotomy via the percutaneous transvenous approach for rheumatic mitral stenosis performed in Babylon‚ Iraq‚ achieves a hemodynamic improvement and procedural success rate similar to the global data.
No takes yet. Share an insight, caveat, or question.
Shokry Faaz Alsaad (2026) conducted an observational in Severe rheumatic mitral stenosis (n=86). Inoue balloon mitral commissurotomy vs. Pre-procedural baseline was evaluated on Mean mitral valve area (cm2) (MD 0.88 cm2, p=<0.001). Inoue balloon mitral commissurotomy achieved a 94.2% procedural success rate, significantly increasing the mean mitral valve area from 0.91 to 1.79 cm2 and reducing the mean mitral gradient.
Synapse has enriched 10 related papers. Consider them for comparative context: